L. Roy Papp & Associates LLP Decreases Position in Colgate-Palmolive Company $CL

L. Roy Papp & Associates LLP decreased its stake in Colgate-Palmolive Company (NYSE:CL) by 3.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,578 shares of the company’s stock after selling 670 shares during the period. L. Roy Papp & Associates LLP’s holdings in Colgate-Palmolive were worth $1,780,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Commerzbank Aktiengesellschaft FI boosted its holdings in Colgate-Palmolive by 7.8% in the second quarter. Commerzbank Aktiengesellschaft FI now owns 27,837 shares of the company’s stock valued at $2,530,000 after purchasing an additional 2,015 shares during the last quarter. Callan Family Office LLC boosted its holdings in Colgate-Palmolive by 286.3% in the second quarter. Callan Family Office LLC now owns 18,685 shares of the company’s stock valued at $1,698,000 after purchasing an additional 13,848 shares during the last quarter. Leo Wealth LLC boosted its holdings in Colgate-Palmolive by 71.2% in the second quarter. Leo Wealth LLC now owns 15,945 shares of the company’s stock valued at $1,449,000 after purchasing an additional 6,632 shares during the last quarter. Armstrong Fleming & Moore Inc purchased a new position in Colgate-Palmolive in the second quarter valued at about $271,000. Finally, Maryland State Retirement & Pension System boosted its holdings in Colgate-Palmolive by 2.8% in the second quarter. Maryland State Retirement & Pension System now owns 39,075 shares of the company’s stock valued at $3,552,000 after purchasing an additional 1,076 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.2%

Shares of NYSE CL opened at $77.82 on Friday. The company has a market cap of $62.90 billion, a price-to-earnings ratio of 21.86, a price-to-earnings-growth ratio of 4.05 and a beta of 0.34. Colgate-Palmolive Company has a 12-month low of $77.09 and a 12-month high of $102.61. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock’s 50 day simple moving average is $82.67 and its 200 day simple moving average is $87.99.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business’s revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the business posted $0.91 EPS. Equities research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.43%.

Analysts Set New Price Targets

A number of research analysts recently commented on CL shares. Barclays reduced their price target on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Bank of America reduced their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday. Morgan Stanley decreased their target price on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research report on Thursday, September 25th. Finally, Citigroup decreased their target price on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a research report on Monday, August 4th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $93.23.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.